Related Experiment Video
Updated: Aug 6, 2026
10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
State pharmacy regulators' opinions on regulating pharmaceutical care outcomes
1School of Pharmacy, West Virginia University, Morgantown, USA.
The Annals of Pharmacotherapy
|June 26, 1998
Summary
Pharmacy regulators are open to regulating drug therapy outcomes. However, there is no consensus on who is responsible for pharmaceutical care outcomes, with varied opinions on pharmacy and pharmacist accountability.
Area of Science:
- Pharmacy Regulation
- Pharmaceutical Care
- Healthcare Outcomes
Background:
- State pharmacy regulators' opinions on drug therapy outcomes are crucial for developing effective regulatory frameworks.
- Understanding these opinions informs strategies for regulating pharmaceutical care.
Purpose of the Study:
- To investigate state pharmacy regulators' views on accountability for drug therapy outcomes.
- To explore potential regulatory approaches for pharmaceutical care outcomes.
Main Methods:
- Surveys were distributed to state pharmacy board executive secretaries, encouraging input from staff and board members.
- The survey assessed the utility of 10 regulatory approaches and determined perceived responsibility of pharmacies and pharmacists for drug therapy outcomes.
Main Results:
- Forty-one surveys were returned; all regulatory approaches were deemed potentially useful.
- Three approaches were consistently helpful for regulating pharmaceutical care outcomes.
- Pharmacies were held responsible for system-related deficiencies, while pharmacists were primarily responsible for prescription filling outcomes, with less accountability for direct patient care outcomes.
- Significant variation in responses indicated diverse opinions among regulators.
Conclusions:
- Pharmacy regulators show openness to outcomes-oriented regulatory strategies.
- A clear consensus on the specific responsibilities for pharmaceutical care outcomes among pharmacies and pharmacists has not been established.
Related Concept Videos
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).